|
FAM8A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.07289782297948E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.24351656644239E-12 |
| Normal-vs-Stage2 |
5.183100E-04 |
| Normal-vs-Stage3 |
5.612500E-04 |
| Normal-vs-Stage4 |
1.660920E-03 |
| Stage1-vs-Stage2 |
3.246400E-01 |
| Stage1-vs-Stage3 |
1.993010E-01 |
| Stage1-vs-Stage4 |
2.192400E-01 |
| Stage2-vs-Stage3 |
8.961000E-01 |
| Stage2-vs-Stage4 |
6.170000E-01 |
| Stage3-vs-Stage4 |
7.300200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.92286203521053E-12 |
| Normal-vs-AfricanAmerican |
2.76720000025321E-07 |
| Normal-vs-Asian |
8.190000E-02 |
| Caucasian-vs-AfricanAmerican |
2.249400E-01 |
| Caucasian-vs-Asian |
7.448800E-01 |
| AfricanAmerican-vs-Asian |
9.217000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59983137848485E-13 |
| Normal-vs-Female |
1.027370E-04 |
| Male-vs-Female |
2.423900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.04299999970081E-07 |
| Normal-vs-Extreme_Weight |
1.69086966650411E-13 |
| Normal-vs-Obese |
2.1038999999945E-06 |
| Normal-vs-Extreme_Obese |
3.03499999998458E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.955600E-01 |
| Normal_Weight-vs-Obese |
2.175600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.125000E-01 |
| Extreme_Weight-vs-Obese |
8.222400E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.153200E-01 |
| Obese-vs-Extreme_Obese |
3.217000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.111600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.68039999482295E-08 |
| Normal-vs-Age(61-80Yrs) |
1.02140518265514E-14 |
| Normal-vs-Age(81-100Yrs) |
7.12990000373281E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.952200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.779400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.807900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.038500E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.304300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.630000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.81008591133059E-12 |
| Normal-VS-Type2 PRCC |
2.61759947051132E-10 |
| Normal-VS-KIRP CIMP |
6.973800E-01 |
| Normal-VS-Unclassified PRCC |
1.57150000001938E-06 |
| Type1 PRCC-VS-Type2 PRCC |
6.333200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.456300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.229000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.076400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.972800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.100300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.65461044444282E-12 |
| Normal-vs-N1 |
2.116300E-02 |
| Normal-vs-N2 |
2.196100E-03 |
| N0-vs-N1 |
1.142230E-02 |
| N0-vs-N2 |
6.261800E-01 |
| N1-vs-N2 |
5.048400E-01 |
|
|
